Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

DNA methylation-based immune cell profiling in mouse blood using MouseRS-CMD.

Genome biology·2026

Same author

Plant Viral Vectors for Vaccine Development.

Vaccines·2026

Same author

Effects and mechanisms of monoclonal and polyclonal human antibodies in protection of humanized mice from HIV-1 challenge.

bioRxiv : the preprint server for biology·2025

Same author

Nano-icilin-driven TRPM8 activation elicits immunogenic exosomes with antitumor effects.

Nanomedicine (London, England)·2025

Same author

Bioimaging application and growth-promoting behavior of Auxin-derived carbon dots on cancer cell and seed performance.

Journal of biological engineering·2025

Same author

Unlocking Opportunities and Overcoming Challenges in Genetically Engineered Biofortification.

Nutrients·2025

Search research articles

Related Experiment Video

Updated: Aug 27, 2025

Viral Nanoparticles for In vivo Tumor Imaging

Viral Nanoparticles for In vivo Tumor Imaging

Published on: November 16, 2012

Multifunctional Plant Virus Nanoparticles for Targeting Breast Cancer Tumors.

Mehdi Shahgolzari¹, Hassan Dianat-Moghadam², Afagh Yavari³

¹Dental Research Center, Hamadan University of Medical Sciences, Hamadan 6517838636, Iran.

|September 23, 2022

Summary

Plant-virus-based nanoparticles (PVNPs) show promise in preclinical breast cancer treatment, offering targeted delivery of therapies and immune agents for enhanced antitumor responses.

Keywords:

active targeting immunomodulatory agent in situ vaccination passive targeting plant viruses

More Related Videos

Analysis of Targeted Viral Protein Nanoparticles Delivered to HER2+ Tumors

Analysis of Targeted Viral Protein Nanoparticles Delivered to HER2+ Tumors

Published on: June 18, 2013

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Published on: June 13, 2014

Related Experiment Videos

Last Updated: Aug 27, 2025

Viral Nanoparticles for In vivo Tumor Imaging

Viral Nanoparticles for In vivo Tumor Imaging

Published on: November 16, 2012

Analysis of Targeted Viral Protein Nanoparticles Delivered to HER2+ Tumors

Analysis of Targeted Viral Protein Nanoparticles Delivered to HER2+ Tumors

Published on: June 18, 2013

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Published on: June 13, 2014

Area of Science:

Biotechnology
Nanomedicine
Oncology

Background:

Plant-virus-based nanoparticles (PVNPs) are emerging as effective platforms in preclinical breast cancer research.
PVNPs offer versatile nanocarrier systems for drug delivery and immunotherapy.

Purpose of the Study:

To review current breast cancer treatments utilizing PVNP platforms.
To highlight the potential of PVNPs in delivering therapeutic agents and activating antitumor immunity.

Main Methods:

Review of preclinical studies on PVNP-based breast cancer therapies.
Analysis of PVNP applications in targeted and non-targeted drug delivery.
Examination of PVNP use in cancer vaccines and combination therapies.

Main Results:

PVNPs demonstrate success in preclinical breast cancer models.
PVNP platforms can encapsulate diverse therapeutic agents and targeting ligands.
Combination of PVNPs with other therapies enhances treatment efficacy.

Conclusions:

PVNP platforms represent a promising strategy for advanced breast cancer treatment.
Targeted delivery and immune activation are key benefits of PVNP-based therapies.
Further research into PVNP applications could significantly impact oncotherapy.